INTRODUCTION:
The adaptive immune system has evolved to mount different types of responses that are matched to the type of invading pathogen. For CD4 + T cells, this is predicated on the multipotentiality of clonally restricted naïve T cells, which differentiate into distinct subsets of effector T cells contingent on recognition of cognate antigen and cytokine cues from cells of the innate immune system. There are two broad divisions of effector CD4 + T cells: T follicular helper (T FH ) cells, which are programmed to interact with B cells within lymphoid tissues to support production of high-affinity, class-switched antibodies, and non-T FH effector cells, including T helper 1 (T H 1), T H 2, and T H 17 cells, which are programmed to egress from lymphoid tissues to orchestrate heightened innate immune cell function at sites of pathogen entry. The mechanisms controlling bifurcation into T FH versus non-T FH effector cell pathways are incompletely understood.
RATIONALE: An impediment to understanding mechanisms controlling T FH -non-T FH cell divergence is an absence of early markers to define cells destined for these alternative fates. Unlike effector CD4 + T cells, which produce a diversity of cytokines that define their phenotype and function, naïve CD4 + T cells are largely limited to the rapid production of interleukin-2 (IL-2) when activated by antigen. IL-2 is only produced by a subset of activated naïve T cells, suggesting a possible relationship between IL-2 production and effector cell fate determination. To explore this, we developed two IL-2 reporter mice strains with complementary features that enabled the tracking and deletion of T cells on the basis of differential IL-2 expression. This allowed us to determine whether naïve T cells that do, or do not, produce IL-2 are biased in their developmental programming and, if so, how.
RESULTS: RNA sequencing of naïve T cells sorted on the basis of IL-2 reporter expression identified cosegregation of transcripts encoding IL-2 and Bcl6-the signature transcription factor of T FH cells. Conversely, IL-2-negative (IL-2 -) cells preferentially expressed the gene Prdm1, which encodes the transcriptional repressor Blimp1. Blimp1, in turn, antagonizes Bcl6 and the T FH developmental program. This suggested that IL-2 producers give rise to T FH cells, whereas IL-2 nonproducers give rise to non-T FH effector cells. Moreover, the fact that IL-2 receptor signaling induces expression of Prdm1 via Stat5 suggested that IL-2 producers resisted IL-2 signaling and activated IL-2 signaling in nonproducers in trans. Indeed, in vivo studies established that IL-2 signaling was mostly paracrine and that depletion of IL-2-producing cells selectively impaired T FH cell development. Finally, IL-2 expression was limited to a subset of naïve T cells that received the strongest T cell receptor (TCR) signals, establishing a link between TCR signal strength, IL-2 production, and T FH versus non-T FH differentiation.
CONCLUSION: This study provides new insights into the mechanisms that control early bifurcation of CD4 + T cells into T FH and non-T FH effectors. Naïve T cells that receive differing strengths of TCR signals stratify into those that exceed a threshold predisposing them to IL-2 production and early T FH commitment and those that do not express IL-2 yet receive IL-2 signaling, which reinforces non-T FH effector commitment. 
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In response to infection, naïve CD4 + T cells differentiate into two subpopulations: T follicular helper (T FH ) cells, which support B cell antibody production, and non-T FH cells, which enhance innate immune cell functions. Interleukin-2 (IL-2), the major cytokine produced by naïve T cells, plays an important role in the developmental divergence of these populations. However, the relationship between IL-2 production and fate determination remains unclear. Using reporter mice, we found that differential production of IL-2 by naïve CD4 + T cells defined precursors fated for different immune functions. IL-2 producers, which were fated to become T FH cells, delivered IL-2 to nonproducers destined to become non-T FH cells. Because IL-2 production was limited to cells receiving the strongest T cell receptor (TCR) signals, a direct link between TCR-signal strength, IL-2 production, and T cell fate determination has been established.
N aïve CD4
+ T cells are multipotent precursors that differentiate into functionally distinct effector subsets to coordinate different aspects of immunity. T helper 1 (T H 1), T H 2, and T H 17 cells are products of developmental pathways induced by different classes of pathogens. They are programmed to egress from T cell zones of secondary lymphoid tissues soon after induction to orchestrate heightened innate immune cell function at sites of pathogen entry. T follicular helper (T FH ) cells develop concurrently with T H 1, T H 2, and T H 17 cells but are programmed to migrate to B cell zones within secondary lymphoid tissues. They provide help to B cells to support the production of high-affinity, classswitched antibodies. T FH -and non-T FH effector cell development diverges early in evolving adaptive responses. However, the type of immune response (type 1, 2, or 3) is linked such that pathogen-clearance mechanisms mediated by innate immune cells are amplified by coordinated help from non-T FH cell effectors and the antibodies that result from T FH cell-mediated B cell help. Cytokines elicited from innate immune cells by pathogens appear to be dominant in determining the type of adaptive response (1) , whereas the intensity of T cell receptor (TCR) signaling appears to contribute to T FH -non-T FH cell specification (2) by mechanisms that are incompletely understood.
An impediment to understanding the mechanisms controlling T FH -non-T FH cell divergence is the absence of reliable early markers to define cells destined for these alternative fates. Unlike effector CD4 + T cells, which are distinguished by a diversity of cytokines that define their phenotype and function, naïve CD4 + T cells are largely limited to the production of interleukin-2 (IL-2), which is produced rapidly by a subset of antigenactivated cells (3) . Through the activation of Stat5 and induction of Blimp1 (4, 5), IL-2 suppresses Bcl6-a central T FH transcription factorand, consequently, T FH development (6) . This implies a direct relationship between the production of IL-2 by naïve CD4 + T cells and their development into either non-T FH or T FH effector cells. We explored this relationship using transgenic mice engineered to report the expression of IL-2.
IL-2 and Bcl6 expression cosegregate within hours of naïve T cell activation IL-2.eGFP reporter mice were generated by the targeted insertion of an IRES-eGFP (internal ribosome entry site-enhanced green fluorescent protein) expression cassette into the fourth exon of the endogenous Il2 gene (Fig. 1A) . Naïve CD4 (Fig. 1, B to E). Reporter expression was rapidly detectable and peaked at approximately 24 hours before declining. This decline lagged production of IL-2 because of the relatively long half-life of the reporter. To define genes differentially expressed by IL-2 producers and nonproducers, CD69 + IL-2 + and CD69 + IL-2 -cells were analyzed by RNA-sequencing (RNAseq) (Fig. 1C) . Among the 151 genes that were preferentially expressed by IL-2 + cells were Bcl6 and the tumor necrosis factor (TNF) superfamily member Cd40l, which are important in T FH cell development or function, respectively. Also enriched in IL-2 + cells was Zbtb32, which, like Bcl6, encodes a member of the POK/ZBTB family of transcription factors and has been shown to restrict the expression of T H 1 and T H 2 cell cytokines (7) . By contrast, among the 210 genes preferentially expressed by IL-2 -cells were multiple genes characteristic of non-T FH effector cell differentiation, including Prdm1, which encodes Blimp1, as well as S1pr1 and Klf2. Similar results were obtained from an analysis of naïve SMARTA TCR-transgenic IL-2.eGFP CD4 + T cells stimulated with antigen ( fig. S1 ). S1pr1 is required for the egress of non-T FH effector CD4 + T cells from secondary lymphoid tissues (8) , and its expression inhibits T FH development in vivo (9, 10) . Klf2 suppresses T FH differentiation while promoting non-T FH effector cell differentiation, at least in part via the induction of Blimp1 (9) . These findings, which were independently validated by quantitative polymerase chain reaction (qPCR) (Fig. 1, D The differential expression kinetics of Bcl6 and Prdm1 by CD4 + T cells were discordant (Fig. 1D ). Bcl6 expression tracked with Il2 expression and decayed to background levels as Prdm1 expression increased. Indeed, at the peak of differential Bcl6 expression (8 hours), Prdm1 expression remained at background levels in both IL-2 + and IL-2 -cells. Thus, although these transcription factors are believed to be directly antagonistic in the specification of T FH versus non-T FH effectors (12) , the rapid, reciprocal expression of Bcl6 in IL-2 + and IL-2 -fractions was not controlled by Blimp1. Instead, we found differential expression of the gene encoding Mxd1 (also known as Mad1) (Fig. 1C and fig. S3 ), which has been shown to directly bind and down-regulate Bcl6 during the differentiation of germinal center B cells into plasma cells (13) . The contemporaneous, reciprocal expression of Mxd1 and Bcl6 antecedent to the expression of Prdm1 suggests that repression of Bcl6 by Mxd1, rather than by Blimp1, may contribute to the early bifurcation of T FH and non-T FH effectors (Fig. 1D and fig. S3 ).
Although Bcl6, like Blimp1, often acts as a transcriptional repressor, the parallel kinetics (2, 18) . This attenuated type 1 bacterial pathogen was engineered to express peptide antigens, which enabled the tracking of endogenous antigenspecific CD4 + T cell responses with peptideloaded major histocompatibility complex class II (MHCII) (p:MHC) tetramers or transferred TCR-transgenic T cells (2, 19) . Naïve CD4 + T cells from CD45.2 + IL-2.eGFP-SMARTA TCR-transgenic mice were transferred into wild-type (WT) CD45.1 + mice and infected with ActA-Lm that express ovalbumin (OVA) peptide and the gp66 peptide recognized by the SMARTA TCR (ActA-Lm-OVA-gp66). Antigen-activated SMARTA T cells were recovered near the peak of IL-2 expression and sorted into IL-2 + and IL-2 -fractions for differential gene expression analysis by RNA-seq (Fig. 4A ). In agreement with our in vitro findings (Fig. 1C) , IL-2 + cells were significantly enriched for expression of Il2, Bcl6, Zbtb32, and CD40l, whereas IL-2 -cells were significantly enriched for Prdm1, S1pr1, and Klf2. Multiple T H 1 cellassociated transcripts (e.g., Ifng, Il12rb2, Ltb, and Gzmb) were identified in IL-2 -cells, consistent with the induction of type 1 immunity by ActA-Lm. Gene set enrichment analysis (GSEA) identified enhanced activity of multiple effector signaling pathways in IL-2 -cells. Of these, two of the most significant were interferon-and inflammatorysignaling gene sets ( . Not significant (ns), P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; error bars depict SEM.
Notably, Il2ra, which encodes the inducible, high-affinity component of the IL-2 receptor (IL-2ra or CD25) that is up-regulated on activated T cells, was enriched in IL-2 -cells (Fig.  4A) . Accordingly, the hallmark IL-2-Stat5 signaling gene set was significantly enriched in IL-2 -cells (Fig. 4B) . Among a manually curated consensus list of 23 gene sets modulated by IL-2 signaling ( fig. S4C ), those up-regulated in response to IL-2 were enriched in IL-2 -cells, many of which include Il2ra (fig. S4, D and E). By contrast, genes down-regulated in response to IL-2 were enriched in IL-2 + cells. Collectively, these findings support a model in which highly activated naïve T cells up-regulate Bcl6, produce IL-2, and are fated to become T FH effectors. IL-2 producers deliver IL-2 to nonproducers, inducing the latter's up-regulation of Blimp1 and differentiation into non-T FH effectors. To examine the relationship between IL-2 production and utilization in vivo and directly address the fate of IL-2 producers and nonproducers, we generated a second transgenic IL-2 reporter mouse line with features complementary to those of the IL-2.eGFP mice ( 
T FH cells are derived from IL-2 producers
To examine the fate of antigen-activated IL-2-producing and -nonproducing T cells in vivo, 2BiT mice were treated with a depleting antiThy1.1 or nondepleting control antibody (25) immediately before infection with ActA-Lm coexpressing OVA and the antigenic peptides gp66, 2W1S, Cbir1, or FliC (Fig. 5 and fig. S6 ). MHCIItetramer analysis of endogenous CD4 + T cells specific for each of these peptides showed that IL-2 (Thy1.1) expression was restricted to CXCR5 + cells and that the depletion of IL-2-expressing cells preferentially eliminated T FH cells and spared non-T FH (T H 1) effectors, as defined by expression of CXCR5 and PD-1 ( Fig. 5A and fig. S6 ) or CXCR5 and Bcl6 (Fig. 5B) . Notably, the number of non-T FH effectors was not compromised by the depletion of IL-2 producers (Fig. 5C ). This suggested that IL-2 was not required for the clonal expansion of non-T FH effectors. However, this likely reflects the discordant kinetics of IL-2 secretion relative to reporter expression and antibodymediated cell depletion, because IL-2 reporter expression and Stat5 phosphorylation were only partially decreased at the peak of IL-2 expression ( fig. S7) . Thus, T FH effector cells developed from IL-2-expressing precursors, whereas non-T FH effectors did not. Accordingly, IL-2 was a reliable marker with which to distinguish precursors fated to become T FH or non-T FH effector cells.
Although surface markers define T FH cells capable of providing B cell help, T FH cell function is predicated on a subset of T FH cells that localize to the germinal center after productive interactions with cognate B cells. Referred to as germinal center (GC-T FH ) T cells, these cells express high amounts of PD-1, Bcl6, and CXCR5 and support the germinal center response and production of high-affinity, class-switched antibodies (12) . To examine the effects of depletion of IL-2-expressing precursors on the development and function of this T FH cell subset, we characterized the effects of anti-Thy1.1 depletion on antibody responses and the generation of GC-T FH cells. 2BiT mice were immunized with heat-killed Lm (HKLm) (Fig. 5, D to F ), because infection with live Lm does not induce good antibody responses (27) . Anti-Thy1.1 depletion of IL-2-producing T cells reduced the production of Lm-specific immunoglobulin G (IgG) by more than 90% compared with treatment with an isotype control antibody (Fig. 5D) . Similarly, anti-Thy1. Transgene   INTERFERON_ALPHA_RESPONSE  TNFA_SIGNALING_VIA_NFKB  INTERFERON_GAMMA_RESPONSE  TGF_BETA_SIGNALING  IL6_JAK_STAT3_SIGNALING  P53_PATHWAY  HYPOXIA  EPITHELIAL_MESENCHYMAL_TRANSITIO  APOPTOSIS  INFLAMMATORY_RESPONSE  ALLOGRAFT_REJECTION  UV_RESPONSE_DN  REACTIVE_OXIGEN_SPECIES_PATHWAY  UV_RESPONSE_UP  MYOGENESIS  ANGIOGENESIS  APICAL_SURFACE  IL2_STAT5_SIGNALING  COMPLEMENT  HEDGEHOG_SIGNALING  ESTROGEN_RESPONSE_EARLY  NOTCH_SIGNALING  ESTROGEN_RESPONSE_LATE  ANDROGEN_RESPONSE  KRAS_SIGNALING_UP  APICAL_JUNCTION  KRAS_SIGNALING_DN  PANCREAS_BETA_CELLS  CHOLESTEROL_HOMEOSTASIS  PI3K_AKT_MTOR_SIGNALING  HEME_METABOLISM  COAGULATION  WNT_BETA_CATENIN_SIGNALING  XENOBIOTIC_METABOLISM  ADIPOGENESIS  FATTY_ACID_METABOLISM  BILE_ACID_METABOLISM  GLYCOLYSIS  OXIDATIVE_PHOSPHORYLATION  PROTEIN_SECRETION  HALLMARK_SPERMATOGENESIS  PEROXISOME  MITOTIC_SPINDLE  DNA_REPAIR  UNFOLDED_PROTEIN_RESPONSE  MTORC1_SIGNALING  MYC_TARGETS_V2  G2M_CHECKPOINT  MYC_TARGETS_V1  E2F_TARGETS   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 group. Data are representative of three experiments. ns, P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; error bars depict SEM.
To examine the effects on GC-T FH cell differentiation, we transferred equivalent numbers of congenically marked 2BiT and GFP-expressing WT CD4 + T cells into T cell-deficient (Tcrb -/-) mice, which were immunized with HKLm (Fig. 5,  E and F) . Anti-Thy1.1 treatment selectively depleted CD45.1 + 2BiT PD-1 + CXCR5 + T cells and had no significant effect on CD45.2 + GFP + control T cells (Fig. 5E) . The magnitude of reduction was highest among PD-1 hi CXCR5 hi cells. Immunohistology revealed that Thy1.1 depletion dramatically reduced the number of 2BiT CD4 + T cells found within germinal centers, with a compensatory increase in the numbers of WT GFP + T cells, resulting in no change in total numbers of germinal center T cells or B cells (Fig.  5F ). These data establish that functional T FH effectors that populate germinal centers and provide help for class-switched antibody responses in response to type 1 pathogens develop from IL-2-producing precursors.
To extend these findings, we determined whether the in vivo depletion of IL-2 + cells also selectively targeted T FH cells under conditions of type 2 (T H 2) and type 3 (T H 17) immune induction (Fig. 6) . Anti-Thy1.1 treatment of 2BiT mice immunized with OVA by using the T H 2-inducing adjuvant alum resulted in the specific depletion of OVA-specific T FH cells and ablation of germinal center B cell and anti-OVA antibody responses, while sparing OVA-specific non-T FH effectors (Fig. 6A) . Similarly, anti-Thy1.1 depletion of 2BiT mice challenged with the T H 17 cell-inducing enteric pathogen Citrobacter rodentium (28) resulted in a loss of bacterial clearance, the kinetics of which were characteristic of an impaired antiCitrobacter antibody response (29, 30) . This was associated with depletion of T FH cells specific for the immunodominant Citrobacter antigen intimin, as well as a markedly impaired germinal center B cell response (Fig. 6B) . There was no significant decrease in IL-17A-or interferon-g (IFNg)-producing cells in infected spleens (Fig.  6C) , both of which are characteristic of the T cell response against Citrobacter (28). However, a modest, but significant, decrease in T H 17 cells, but not T H 1 cells, was observed in the mesenteric lymph nodes of mice depleted of IL-2 producers (Fig. 6D) . These findings indicate that, in the context of type 3 responses, there is some overlap in the developmental fate of IL-2-producing precursors of T FH and T H 17 effector cells. They also establish that IL-2 + T cells are precursors for T FH cells in the context of type1, type 2, and type 3 effector responses.
IL-2 production and T FH cell differentiation correlate with TCR signal strength
The developmental divergence of T FH and non-T FH cells is influenced by a combination of cell-intrinsic factors, including TCR affinity, and cell-extrinsic factors, such as antigen availability, strength of costimulation, and cytokine milieu. Given its direct correlation with T FH -non-T FH cell fate determination, we examined whether IL-2 expression shared similar mechanistic underpinnings. To examine the relationship between antigen dose, IL-2 expression, and T FH -non-T FH cell specification on T cells of uniform TCR affinity, naïve CD45.2 + IL-2.eGFP-SMARTA T cells were transferred into WT CD45.1 + recipients, which were infected with various doses of ActA-Lm expressing the gp66 peptide (ActA-Lm-OVA-gp66; condition Lm-gp66). Nonspecific effects of Lm-induced inflammatory signals were excluded by keeping the total dose of ActA-Lm constant via coinfection with ActA-Lm expressing an irrelevant specificity (ActA-Lm-OVA-2W1S; condition Lm-2W1S) (Fig. 7, A and B) . Splenic CD45.2 + cells were analyzed for CD69 and GFP (IL-2) expression around the peak of IL-2 expression (Fig. 7A) . The frequencies and absolute numbers of endogenous gp66-specific T FH and non-T FH cells were quantified near the peak of the effector T cell response (Fig. 7B) . The expression of both CD69 and GFP correlated tightly with pathogen-expressed antigen dose, as did the magnitude of clonal expansion and reciprocal T FH versus non-T FH differentiation. There was a similar correlation over a broader dose range of ActA-Lm-OVA-gp66 administered alone ( fig. S9) . Thus, the frequencies of CD69 + and IL-2 + cells correlated positively with Lm-gp66 dose, as did the generation of T FH cells. This indicates that antigen dose-and consequently TCR signal strength-is a major determinant of the fraction of clonal precursors that express IL-2 and are fated to become T FH cells.
The relative development of T FH and non-T FH effectors is also influenced by TCR affinity, which is invariant on individual T cell clones but varies between different clones within the repertoire (2) . In agreement with the strong correlation between differential IL-2 expression and T FHnon-T FH cell bifurcation, we found that two clonal populations of the same precursor frequency, which had differing TCR specificities (OVA versus gp66) and affinities, produced significantly different frequencies of IL-2-expressing T cells in response to the same antigen dose despite no difference in the frequency of cells expressing CD69 (Fig. 7C) . Similarly, the relative frequencies of endogenous T FH and non-T FH cells generated by two TCR specificities of differing TCR affinities diverged in response to the same antigen dose (Fig. 7D ). In accord with these results, T FH cells were characterized by a significantly greater two-dimensional (2D) TCR affinity than non-T FH cells that developed in a polyclonal T cell response to the same antigen (gp66) (Fig. 7E) . Together with our antigen-dose results, these findings support a deterministic function of TCR signal strength in driving T FH versus non-T FH cell development (2), such that higher TCR signaling favors T FH cell development.
To calculate 2D affinity values, normalized adhesion-bond measurements must be adjusted to control for TCR density (31) . Although equivalent in terms of cell size, gp66-specific T FH cells expressed more TCR molecules per cell than non-T FH cells (Fig. 7E) . Similar results were found for OVA-specific and total T FH cells. Accordingly, the difference in the normalized adhesion bond was accounted for by differences in both TCR affinity and TCR number per cell. Thus, we examined the influence of variation in TCR number on T cell activation and IL-2 production ( fig. S10A) (Fig. 7F) . Moreover, when naïve T cells were sorted on the basis of high or low TCRb expression and stimulated with a range of anti-CD3 concentrations, cells with higher TCR numbers showed higher CD69 expression across the full range of anti-CD3 concentrations and expressed increased IL-2 ( fig. S10B) . Thus, in addition to intrinsic TCR affinity differences between T cell clones, variation in TCR number within a clonal population may influence the probability that a given cell will exceed a threshold for activation and expression of IL-2 and, therefore, T FH versus non-T FH cell differentiation.
The expression of CD69 by activated naïve T cells has been shown to correlate linearly with the expression of Myc and Nur77, providing an indicator of graded TCR signal intensity (23, 32) . Yet, on the basis of the observed limitation of IL-2 expression to a subset of the highest CD69 expressors (Figs. 3A and 7A ), our findings suggested that only those T cells that exceeded a minimum TCR signaling intensity produced IL-2, linking T FH -non-T FH cell bifurcation to a threshold of TCR signaling.
To explore this further, the relative expression of CD69 and IL-2 by naïve T cells was assessed under conditions in vitro for which only the intensity of TCR stimulation was varied (Fig. 8A) . The percentage of cells expressing CD69 and IL-2 correlated positively with the dose of anti-CD3, as did expression amounts of CD69 and IL-2, consistent with our in vivo antigen-dose experiments (Fig. 7A and fig. S8A ). However, although the distribution and mean expression of CD69 varied with the intensity of TCR stimulation, CD69 expression among IL-2 + cells was constant, and only cells that exceeded an invariant, high magnitude of CD69 expressed IL-2. A similar effect was seen with the induction of inducible costimulator (ICOS) expression ( fig.  S11A ), which is a functional marker of T FH cell differentiation (33 The expression of Myc, which has been directly correlated with the number of cell divisions that T cells are fated to undergo (24) , was tightly correlated with CD69 expression and thus TCR signal intensity and IL-2 expression (Fig.  8B) . The early expression of E2F family members, which are associated with cell-cycle entry, was limited to cells that exceeded a threshold for IL-2 expression. This was consistent with the GSEA data ( Fig. 4B and fig. S4 ), which indicated that E2F family targets are strongly enriched in IL-2 + cells compared with IL-2 -cells. This suggests that IL-2 + cells enter the cell cycle more rapidly than IL-2 -cells and are likely to undergo a greater number of cell divisions before exiting the cell cycle. Accordingly, T FH effectors demonstrated an increase in the average number of cell divisions relative to non-T FH effectors in vivo (Fig. 8C) . Thus, although IL-2 has traditionally been viewed as a T cell growth factor, precursors of T FH cells, which do not respond to IL-2 despite producing it, appear programmed for earlier cellcycle entry and a greater number of cell divisions than precursors of non-T FH effectors, which do respond to IL-2.
Our results support a model whereby cellintrinsic and -extrinsic variables that influence TCR signal strength contribute to a threshold DiToro depict cell number-controlled concatenated averages. n = 5 or 6 mice per group. Data were analyzed by using Student's t tests. ns, P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; error bars depict SEM. Data were analyzed by using Student's t tests. ns, P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; error bars depict SEM.
that is tightly associated with IL-2 production and T FH cell differentiation. Although TCR affinity and antigen dose clearly contribute to the probability that a cell will attain this threshold, costimulation and cytokine signals can also contribute. It has been shown that transforming growth factor-b (TGFb) signaling can attenuate TCR signaling (34) and limit T cell responses to high-affinity antigens (35) . Indeed, the addition of TGFb significantly reduced the mean expression of CD69 by activated naïve T cells, the proportion of CD69 + cells that produced IL-2, and the mean expression of IL-2, whereas TGFb blockade had the opposite effect ( fig. S12) . However, the percentage of cells that expressed CD69 was unaltered by either intervention. Thus, in addition to modulating TCR-independent signaling cascades that control effector T cell specification, TGFb may also influence IL-2 production by limiting TCR-signal strength without limiting the frequency of naïve T cells that receive activating TCR signals (36) . In this regard, it is notable that the addition of IL-6 overrode the repressive effects of TGFb (T H 17 cell conditions; Fig. 3A ), resulting in significantly higher IL-2 expression. Indeed, this was greater than any other T effector-polarizing condition. Because the major effects of IL-6 are independent of TCR-signal strength and its actions contribute to both T FH and T H 17 cell development, clearly, TCR-independent factors that modulate IL-2 production may affect T FH -non-T FH cell developmental decisions. Furthermore, in view of the shared requirement for IL-6-induced Stat3 signaling and high production of IL-21 by both T H 17 and T FH cells, these data suggest a considerable overlap in the developmental programming of these two subsets and, perhaps, shared regulation of the tightly syntenic Il2 and Il21 loci ( Fig. 2A) .
Discussion
The findings in this study provide new insights into the mechanics that control the early bifurcation of CD4 + T cells into T FH and non-T FH effectors, placing reciprocal production and utilization of IL-2 at the center of this key developmental decision. Because divergent IL-2 signaling and Bcl6 expression have been linked to effector versus central memory, respectively (37) , these results may also have implications for alternate programming of CD4 + T cell memory. Our findings predict that IL-2 nonproducers are fated for effector memory, whereas IL-2 producers are fated for central memory.
It has been proposed that asymmetric cell division results in the partitioning of factors that guide the divergent development of progeny of activated naïve T cells (38) . Although the observation herein that T FH -non-T FH cell fate determination is initially encoded well before cell division does not preclude a role for asymmetric cell division, it does suggest that signaling between T cells that receive differing activation signals likely plays a dominant role. It has been shown that homotypic T cell conjugation mediated by LFA-1-ICAM interactions between activated T cells facilitates directional, paracrine delivery of IL-2 via multifocal synapses (39) . The expression of Icam1 was enhanced on IL-2 -cells in the current study (Figs. 1C and 4A ). Because the kinetics of IL-2 production are within the average dwell time of T cells that form long-lived interactions on an activating dendritic cell (40) (41) (42) , our findings suggest that T cell-T cell interactions that result in directional IL-2 signaling between IL-2 producers and nonproducers may occur on the same dendritic cell, although this will necessitate further study. The role of T reg cells in buffering IL-2 availability to non-IL-2 producers, owing to the constitutive expression of the high-affinity IL-2 receptor and high-avidity LFA-1 by T reg cells will also require additional inquiry.
Results This experiment was performed three times. ns, P > 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; error bars depict SEM.
is not fixed for subsequent responses ( fig. S13) . Thus, IL-2 expression by T FH cell precursors does not ensure IL-2 expression by T FH effectors in a recall response nor does lack of IL-2 expression by non-T FH cell precursors preclude IL-2 expression by non-T FH cell effectors. Nevertheless, the utility of IL-2 as an early marker for cells fated to these different effector programs is established herein. This will offer the opportunity to discover new factors that determine the bifurcation into T FH and non-T FH effectors, as exemplified by the finding of a possible Mxd-Myc-Max axis in controlling the early differential expression of Bcl6. We propose that this should provide a basis for strategies to modulate the balance of effector T cell responses for therapeutic ends.
Materials and methods Mice
B6.Cg-Tg-IL2 tm1(eGFP)Weav (IL-2.eGFP) and B6. IL-2.BAC-inThy1.1 (2BiT) were generated using strategies previously described (25) OT-II IL-2.eGFP, and 2BiT CD45.1 were generated by crosses in UAB's breeding facility. Animals were bred and maintained under specific pathogen-free conditions in accordance with institutional animal care and use committee regulations.
Tissue processing and flow cytometric analysis
Mice were sacrificed by isoflurane euthanisia before removal of spleen and/or lymph nodes. Secondary lymphoid tissues were disrupted by mashing with a syringe in complete RPMI-1640 over a 70-mm filter. Surface staining was performed in PBS with 2% FBS and 0.1% sodium azide. T cells from 2BiT animals were directly stained for surface Thy1.1 (clone HIS5-1) without secondary stimulation. For identification of T FH , cells were incubated with biotinylated anti-CXCR5 for 1 hour at room temperature, then washed and incubated with streptavidin-APC or PE-Cy7 and additional surface markers for 20 min at 4°C. Intracellular staining for transcription factors was performed using either BD Fix/Perm or eBioscience Foxp3 staining kits. For ex vivo phospho-Stat staining, freshly harvested splenocytes were fixed for 10 min at 37°C in 4% PFA in PBS, stained with eFluor450-or PacBlueconjugated anti-Thy1.1, refixed with 4% PFA in PBS and permeabilized in 90% MeOH for 30 min on ice. Following this, cells were stained for phosphorylated Stat5 and additional markers at room temperature for 1 hour. Alternatively, cells were fixed in 4% PFA in PBS for 10 min at 37°C, permeabilized in 90% MeOH for 30 min on ice, and then stained for 1 hour at room temperature.
Absolute T and B cell numbers were calculated using PKH reference beads (Sigma-Aldrich) or concentration values (events per microliter) obtained on the Attune NxT. Absolute TCRb numbers were calculated using BD Quantibrite Beads Fluorescence Quantification Kits. Briefly, cells were stained at saturating concentrations of PE-labeled anti-TCRb (clone H57-597). A standard curve generated from PE Quantibrite Beads was then used to transform TCRb MFI measurements into absolute quantifications.
All flow cytometric data were acquired on an Attune NxT (Thermo Fisher Scientific), LSRII, or an Aria II (BD Immunocytometry Systems, San Jose, CA) and analyzed with FlowJo software (Tree Star, Eugene, OR). . SMARTA IL-2.eGFP T cells isolated ex vivo from acutely activated recipient mice were processed from tissue by negative selection with biotinylated antibodies to CD11b, CD11c, and B220, streptavidin-conjugated microbeads, and LS columns (Miltenyi Biotech). Column flow-through fractions were then stained for a congenic marker (Thy1.1, Thy1.2, or CD45.2) before sorting as above.
T cell isolation
In vitro T cell activation
Sorted naïve T cells were activated in complete RPMI-1640 (RPMI medium containing 10% FBS, 100 IU/ml penicillin, 100 mg/ml streptomycin, 1 mM sodium pyruvate, nonessential amino acids, 50 mM b-mercaptoethanol and 2 mM l-glutamine) for 4 to 36 hours with anti-CD3 (2.5 mg ml ), and irradiated splenocytes at a 5:1 ratio of splenocytes to T cells under nonpolarizing conditions (i.e., without additional cytokines or antibodies). In some experiments, sorted naïve T cells were activated with a range of plate-bound anti-CD3 concentrations and 0.5 mg/ml anti-CD28 or a range of soluble anti-CD3 concentrations and irradiated feeders at a CD4:feeder ratio of 1:5.
For restimulation of splenic T FH and non-T FH cells, magnetically enriched splenic CD4 + T cells were stained simultaneously with tetramer and biotin-labeled anti-CXCR5 (see table above) for 1 hour at room temperature. Cells were then washed and stained with fluorophore-labeled streptavidin and PD1 for 20 min at 4°C. Labeled cells were then incubated for 4 hours in complete RPMI with 2 mg/ml anti-CD28 on flat-bottom 96-well plates precoated with 5 mg/ml anti-CD3. Following restimulation, cells were stained for CD69, CD44, CD4, additional surface markers, and viability dye for 15 to 20 min at 4°C.
Adoptive transfer and Ab-mediated in vivo depletion
For adoptive transfer experiments examining IL-2.eGFP or IL-2.Thy1.1 expression at early time points, 1 × 10 6 to 2.5 × 10 6 naïve cells were injected i.v. into congenic recipient mice infected 24 hours before transfer unless otherwise indicated. For experiments involving cotransfer of Smarta.IL-2.eGFP and OT-II.IL-2.eGFP donor cells, 5 × 10 5 sorted naïve cells of each donor strain were injected retro-orbitally (RO) into mice infected 24 hours before transfer. For adoptive transfer experiments examining T FH differentiation three or more days after transfer, 5 × 10 4 sorted naive donor cells were injected RO into congenic recipients infected 24 hours before transfer unless otherwise indicated. For cotransfer into TCRb KO recipients, 1 × 10 6 magnetically enriched bulk CD4 + T cells from wild-type B6 or transgenic eGFP and CD45.1 2BiT congenic mice were injected RO into TCRb-deficient mice followed by infection 1 day after transfer. For depletion of IL-2.Thy1.1 (2BiT) cells in vivo, mice were given a single intraperitoneal injection of 250 mg of anti-Thy1.1 or isotype monoclonal antibody 24 hours before infection or immunization.
Infections and protein immunizations Lm
Mice were immunized i.v. with 200 ml of PBS containing live (dose as indicated) or heat-killed Actin A-deficient Listeria monocytogenes (ActA -Lm; 2 × 10 9 to 2 × 10 10 ) (18) . All Lm strains used were transformed by a plasmid containing OVA 250-387 and one of four different IA b -specific "foreign" peptides: (i) a mutant epitope of I-Ea ("2W1S"); (ii) flagellin peptide 456-475 from Clostridium ("Cbir1"); (iii) glycoprotein 66-77 peptide of LCMV ("gp66"); or (iv) flagellin peptide 427-441 from Salmonella typhimurium ("FliC") all expressed under the control of the hly (listeriolysin O) promoter. All Lm strains were produced in the laboratory of S.-S. Way as previously described (44) . Bacteria were grown in brain-heart infusion (BHI) medium with 15 mg/ml chloramphenicol to an absorbance of >0.1 at 600 nm, and doses varied as indicated. The actual number of live bacteria injected was confirmed by dilution and growth on BHI agar plates containing chloramphenicol.
OVA/CFA
Mice were immunized i.p. with 100 ml of a 100-mg chicken egg ovalbumin emulsion in CFA.
OVA/Alum
Mice were injected i.p. with 200 ml of a 0.5-mg/ ml emulsion of chicken egg ovalbumin in alum. The emulsion was prepared by mixing 1 mg/ml ovalbumin dissolved in water (Invivogen vac-pova) 1:1 with alum (FisherScientific Imject Alum 77161).
Citrobacter rodentium
Mice were orally gavaged with 1 × 10 9 to 2 × 10 9 CFU of Citrobacter rodentium strain DBS100 (ATCC 51459) or the bioluminescent ICC180 derivative (generously provided by G. Frankel and S. Wiles, Imperial College London). Mice infected with the ICC180 derivative were shaved and imaged with an IVIS 100 Imaging System (Xenogen, Inc.) as previously described (28) .
RNA-seq and analysis
For sample preparation and hybridization, total RNA was isolated from purified naïve (CD4 + or CD8a T cells with Qiazol and miRNeasy micro kits according to manufacturer's recommendations (Qiagen). Library preparation was performed using Illumina TruSeq techonology. Samples were processed at UAB Heflin Center for Genomic Science for Next Generation Sequencing (NGS) or La Jolla Institute (LJI) using the Illumina HiSeq 2000 Sequencing System. Reads were mapped to the mm10 genome using TopHat (version 2.0.12) (45) . BAM files were sorted using SAMtools (version 0.1.19) (46), and reads were counted for each gene using HTSeq (version 0.6.1) (47) and NCBI Mus musculus Annotation Release 106 (GRCm38.p4). RNA expression was normalized using the rlog function from the DEseq2 R package (version 1.8.2) (48). Differential gene expression analysis was performed using DEseq2, and P values were corrected with the Benjamini-Hochburg procedure. Volcano plots were created using the ggrepel R package. To calculate gene set enrichment, a differential expression probability density function (PDF) was determined for each gene using Quantitative Set Analysis for Gene Expression (QuSAGE) (49) . PDFs were combined for each gene set to calculate gene set activity after correcting for gene-gene correlation. Gene set PDFs were compared using Welch's t test, and P values were adjusted using the Benjamini-Hochberg procedure.
Statistical analysis
Experimental P values were calculated using unpaired Student's t tests, Welch's t tests, or one-way or two-way ANOVA tests with Tukey's post hoc multiple comparisons analysis. A P value of <0.05 was considered significant. See figure legends for details.
